Can medicines management services reduce hospital admissions?

Pharmaceutical Journal

Volumn 280, Issue 7487, 2008, Pages 123-126

  Petty, Duncan ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; LONG ACTING DRUG; LOOP DIURETIC AGENT; METFORMIN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STEROID; TIOTROPIUM BROMIDE; WARFARIN;

ACUTE CORONARY SYNDROME; ANGIONEUROTIC EDEMA; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONSULTATION; DEHYDRATION; DOSE KIDNEY FUNCTION RELATION; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; EMERGENCY CARE; FALLING; FLUID RETENTION; GAIT DISORDER; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEMATOMA; HEMATURIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOTENSION; INTERDISCIPLINARY COMMUNICATION; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; LONG TERM CARE; LOW DRUG DOSE; MEDICAL RECORD; NATIONAL HEALTH SERVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOSTATIC HYPOTENSION; OSTEOARTHRITIS; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; POLYPHARMACY; PRESCRIPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; UNITED KINGDOM;

EID: 39049083009     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Department of Health. NHS improvement plan. London: The Department, 2004.
2. Howard RL, Avery AJ, Howard P, Partridge M. Investigation into the reasons for preventable drug-related admissions to a medical admissions unit: observational study. Quality & Safety in Health Care 2003; 12:280-5.
3. Pirmohamed M, James S, Meakin S, Green C. Adverse drug reactions as cause of admission to hospital. BMJ 2004;329:15-9.
4. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Quality and Safety in Health Care 2006;15:23-31.
5. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323:1340-3.
6. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005;330:293.
7. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care - the POLYMED randomised controlled trial. Age and Ageing 2007;136:292-7.
8. Krska J, Hansford D, Seymour DG, Farquharson J. Is hospital admission a sufficiently sensitive outcome measure for evaluating medication review services? A descriptive analysis of admissions within a randomised controlled trial Can pharmacists' interventions show an impact on hospital admissions? An evaluation of the contribution of pharmaceutical care issues to admission. International Journal of Pharmacy Practice 2007;15:85-91.
9. Lowe CJ, Petty DR, Zermansky AG, Raynor DK. Development of a method for clinical medication review by a pharmacist in general practice. Pharmacy World and Science 2000:22:121-6.
10. Institute for Innovation and Improvement. Delivering quality and value. Available at: www.institute.nhs.uk (accessed 1 October 2006).
11. National Institute of Health and Clinical Excellence. Guideline No 5 - chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. London: Royal College of Physicians, 2003.
12. Study Group of Diagnosis - part of the Working Group on Heart Failure at the European Society of Cardiology. The Euro heart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. European Heart Journal 2003;24:464-74.
13. Petty DR, Silcock J, Zermansky AG, Raynor DK. A survey of general practitioners' perceptions of beta-blocker therapy for heart failure. International Journal of Pharmacy Practice 2007; Supp2, B29-30.
14. Clinical Evidence. Beta blockers for heart failure. Available at: www.clinicalevidence.com (accessed 27 April 2005).
15. National Institute of Health and Clinical Excellence. CG12 - chronic obstructive pulmonary disease. Available at: guidance.nice.org.uk/CG12/ niceguidance/pdf/English (accessed 28 January 2008).
16. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003;290:2301-12.
17. Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Baltimore: John Hopkins University Press, 1979.
18. A competency framework for shared decision-making with patients. Achieving concordance for taking medicines, January 2007. Available at: www.npc.co.uk (accessed 28 January 2008).
19. Salter, C., Holland, R., Harvey, I., Henwood, K. (2007). "I haven't even phoned my doctor yet." The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. BMJ 2007;334:1101.
20. Leipzig RMCR, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis - psychotropic drugs. Journal of the American Geriatric Society 1999;47:30-9.
21. Sorensen HT. Medication management at home: medication-related risk factors associated. with poor health outcomes. Age and Ageing 2005;34:626-32.
22. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2005.
23. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, Bowie P. Clinical medication review by a pharmacist of elderly people living in care homes - randomised controlled trial. Age and Ageing 2006;35:586-91.
24. Non-steroidal anti-inflammatory drugs. In: British National Formulary 52. London: BMJ Publishing Group and RPS Publishing, 2006.
25. Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Systematic Review 2006.
26. National Institute of Health and Clinical Excellence. Guideline No 34 - hypertension: management of hypertension in adults in primary care. June 2006.
27. National Institute for Health and Clinical Excellence. Technology appraisal 80. Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome. July 2004.